HSBC Holdings
ATRA icon

HSBC Holdings’s Atara Biotherapeutics ATRA Stock Holding History

HSBC Holdings’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-451
Closed -$7.82K – 2939
2024
Q1 		$7.82K Buy
+451
New +$8.01K ﹤0.01% 3019
2019
Q4 		– Sell
-485
Closed -$171K – 3027
2019
Q3 		$171K Buy
+485
New +$181K ﹤0.01% 2904
2018
Q3 		– Sell
-2,977
Closed -$2.73M – 2534
2018
Q2 		$2.73M Sell
2,977
-249
-8% -$267K ﹤0.01% 1398
2018
Q1 		$3.15M Buy
+3,226
New +$2.94M ﹤0.01% 1275

Other funds holding ATRA

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return